首页 正文

EZH2 Inhibition Remodels Cell States and Enhances EGFRi Sensitization in Bladder Cancer

{{output}}
Background: Bladder cancer (BCa) displays interpatient heterogeneity and epigenetic plasticity that may limit treatment efficacy. Objective: To... ...